THE RÔLE OF THE MUCOID POLYSACCHARIDE (HYALURONIC ACID) IN THE VIRULENCE OF GROUP A HEMOLYTIC STREPTOCOCCI by Kass, E. H. & Seastone, C. V.
THE  ROLE  OF  THE  MUCOID  POLYSACCHARIDE  (HYALURONIC 
ACID)  IN  THE VIRULENCE  OF  GROUP  A 
HEMOLYTIC  STREPTOCOCCI 
BY E. H. KASS, PH.D., AND C. V. SEASTONE, M.D. 
(From the Department of Bacteriology, The University of Wisconsin 
Medical School, Madison) 
(Received for publication,  November 26, 1943) 
While it is generally agreed that  the capsular polysaccharide of hemolytic 
streptococci of  Lancefield group  C  is  an  important  virulence  factor  (1-3), 
the  capsular  polysaccharide  of  group  A  streptococci,  although  apparently 
identical with that of the group C streptococcus, has been considered only a 
minor  factor  in  virulence  (2--4).  The  latter  conclusion is  based  chiefly on 
evidence presented by Hirst (2), who infected mice with group A and group C 
streptococci and treated these animals with leech extract containing the specific 
decapsulating  and  hydrolyzing  enzyme,  hyaluronidase.  Such  treatment 
protected against  the group C strain but gave only feeble protection against 
the group A organisms.  Similarly, Blundell (5) found that mice infected with 
a  group A  strain and treated with bovine testicular extract showed a  greater 
mean survival time than the untreated controls, but the protective action was 
weak.  Attempts by McClean, however, (6) to repeat the observations of Hirst 
and of  Blundell using  testicular  hyaluronidase have been unsuccessful,  even 
with  group  C  organisms,  despite  the  use  of amounts  of enzyme  greatly in 
excess of those necessary to bring about decapsulation in vitro. 
The consistent presence of hyaluronic acid in group  A streptococci isolated 
from human  infections  (7)  and  its  capsular  location,  indicate  the  likelihood 
that  the  polysaccharide  is  more  important  than  would  appear  from  these 
observations. 
Many earlier  workers  have suggested  a  basic  rble  in virulence  for the capsule. 
Border (8), in  1897, related the infectivity of streptococci  to an  "areola"  which is 
present particularly in young streptococci,  and which enables the organisms to resist 
phagocytosis,  and Hare (11) demonstrated that as virulent streptococci age, they are 
more readily phagocytosed.  That young streptococci are encapsulated  was confirmed 
by Seastone (9), who also showed that removal of the capsules by aging or heat treat- 
ment is associated  with increasing  susceptibility  to phagocytosis.  Kendall, Heidel- 
berger, and Dawson (10) isolated the capsular carbohydrate and indicated its probable 
identity with hyaluronic acid, a polysaccharide first found by Meyer and Palmer (12) 
in bovine vitreous humor and human umbilical cord.  Hyaluronie acid has since been 
obtained from such diverse sources as skin (13), synovial fluid (14), fowl tumors (15, 
16), a human mesothelioma  (17), and from group C streptococci (1).  Attempts to 
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produce an antibody to the polysaccharide have so far been unsuccessful, probably 
because the polysaccharide is a  natural constituent of mammalian tissues. 
Enzymes capable of hydrolyzing hyaluronic acid have been obtained from pneumo- 
coccal autolysates  (18),  testicular  extract  (19,  20),  spleen  (21),  some non-mucoid 
hemolytic streptococci (21, 22), Cloaridium welchii cultures (23, 24), snake and spider 
venoms (25), leeches (26), and from extracts of various tumors (16); hyaluronidase has 
been identified as one of the spreading factors (4,  19, 27). 
The present studies are concerned with the protective effect of hyaluronidase 
on group A streptococcal infection, in the belief that  the demonstration of such 
protection would establish the capsule as one of the basic factors in the virulence 
of group A  streptococci. 
Materials and Methods 
Media and Cultures.--The  stock medium used throughout was a 2 per cent bacto- 
tryptose, 1 per cent dextrose solution (pH 7.6-7.8) with sterile sheep serum added as 
needed.  For culturing the pneumococcal strain used in these experiments, 1 per cent 
sheep serum broth was used; for the streptococcal strains, the serum was added to 20 
per  cent  concentration.  The  pneumococci were  maintained  in  meat  tubes  under 
mineral oil, whereas the streptococci were transferred monthly on 5 per cent sheep 
blood agar plates; all strains were passed through mice frequently to maintain viru- 
lence. 
Preparation of Hyaluronic Add.--The  method of purification  of vitreous humor 
polysaccharide was that of Seastone  (1).  The umbilical cords used  as a  source of 
hyaluronic acid were collected under acetone, minced with saline in a Waring blender, 
and  the  extract  purified  by the  same  method. 
Preparation of Hyaluronidase.--Freshly  obtained bull testicles were stripped free of 
epididymis and fibrous connective tissue coverings, and minced in a Waring blender 
with  an equal weight of distilled  water.  The suspension was centrifuged and  the 
turbid, red-brown supernatant brought to pH 4.5 (glass electrode) with 2 N acetic acid. 
After 1 hour in the refrigerator,  a large, essentially inactive precipitate settled out, 
leaving a  clear red  or amber supernatant  which was neutralized  with  5 I~ NaOH, 
centrifuged, and filtered through a bacteria-retaining sintered glass filter.  The solu- 
tion can be either dried by lyophilization, or preserved in the frozen state in the refrig- 
erator.  The frozen solutions proved stable, with less than 20 per cent loss in activity 
after  storage  for  2  months. 
Estimation of Hyaluronidase A ctivity.--Because of the inconvenience of the viscosi- 
metric method of McClean and Hale (23), a procedure was developed for measuring 
hyaluronidase activity by turbidimetric means.  Since the turbidity produced when 
hyaluronic acid is mixed with acidified protein is a function of the concentration of the 
polysaccharide  (1),  reference  turbidity  curves  may  be  plotted  by  adding  known 
amounts of purified hyaluronic acid to acidified  protein under standard conditions. 
The acidified  protein solution is prepared by diluting horse serum  1:10 with 0.5 M 
acetate buffer (pH 4.2), and adding 4 ~r HC1 until pH 3.1 is reached (7).  In all experi- 
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the polysaccharide (usually contained in a  volume not exceeding 1 ml.) to sufficient 
0.5 ~r acetate buffer (pH 4.2) to bring the final volume to 4 ml.  To this solution is 
added 1 ml. of the acidified serum; the turbidity is allowed to develop for 30 minutes 
and is determined in a Klett-Duboscq photoelectric colorimeter using various thick- 
nesses of plate glass for standards.  This turbidity estimation may also be utilized as 
a  rapid means for following the purification of the polysaccharide, since, if a  given 
weight of a sample fails to produce as much turbidity as the same amount of highly 
purified polysaccharide, it is evident that not all of the weight of the former sample is 
hyaluronic acid. 
For the estimation of hyaluronidase activity, the enzyme is diluted with pH 6.0 
buffer (0.1  ~)  and allowed to warm for 5 minutes in a  37°C. water bath.  Purified 
polysaccharide, diluted in the same buffer to a concentration of 0.4 mg./ml, is warmed 
at  the same time, and  equal amounts  of polysaccharide and  enzyme solutions are 
mixed and incubated.  At regular intervals 1 ml. samples are removed from the react- 
ing mixture and added to a  tube containing 3 ml. acetate buffer (pH 4.2) and  1 ml. 
acidified serum; after 30 minutes at room temperature, the turbidity is read as pre- 
viously outlined.  One  turbidity-reducing unit has been arbitrarily defined as that 
amount of enzyme which in 30 minutes will reduce the turbidity produced by 0.2 mg. 
of hyaluronic acid to the equivalent of the turbidity produced by 0.1 mg.  The tur- 
bidity equivalent to that produced by half the initial amount of polysaccharide is the 
half-turbidity point. 
As turbidity forms in the presence of the enzyme, the latter may continue to act on 
the polysaccharide and decrease the final turbidity.  Many other factors may, how- 
ever, combine to  decrease the activity of the enzyme after sampling; the  dilution 
which the reacting mixtures undergo upon being added to four volumes of buffer and 
serum, as well as the change to a  less favorable pH, tend to slow the reaction rate. 
Probably an even more important inhibitory factor is the effect of the polysaccharide- 
protein combination.  Preliminary experiments showed that approximately ten times 
more enzyme is required to reduce the turbidity of a preformed polysaccharide-protein 
precipitate, than to reduce the capacity of the polysaccharide alone to precipitate acid 
protein. 
In order that the turbidity readings be accurate, the enzyme contained in the sample 
must have no appreciable effect on the formation and subsequent stability of the pre- 
cipitate during the time which elapses between sampling and reading the turbidity. 
In a series of duplicate experiments, the standard amount of polysaccharide was incu- 
bated with  1,  2,  and 3  units of hyaluronidase, and  samples were removed every 5 
minutes until the half-turbidity  point had been passed.  The turbidity formed by each 
sample was read exactly ~, 1, 2, and 18 hours after sampling.  The turbidity produced 
by samples from the tubes containing 1 and 2 units of enzyme was unaffected by 2 
hours standing at room temperature, although about 20 per cent decrease occurred 
during the 18 hour period; the turbidity produced by samples from the tube containing 
3 units was unaffected by 1 hour standing, but showed a  15 per cent decrease after 2 
hours.  From these experiments it is seen that if the half-turbidity point is attained 
in less than 15 minutes, i.e., if more than 2 units are present, the readings must be made 
within an hour to be accurate.  It would, however, be more precise to accept as valid 
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15 to 45 minutes.  If the half-point falls within this time range, the tubes in which the 
turbidity has formed may stand up to 2 hours without affecting the readings.  Thus, 
the entire enzyme estimation procedure can be conducted without halting to read the 
turbidity formed by the first samples, and all tubes can be read after a period of 30 
minutes following the withdrawal of the last sample, as long as the total time between 
the initial mixing of enzyme and polysaccharide and the time when the last turbidity 
reading is taken does not exceed 2 hours.  Customarily, the procedure has been to 
withdraw samples 15, 25, 30, 35, and 45 minutes after the time of mixing. 
In cases where there is no previous indication of the approximate concentration of 
enzyme in a given solution, samples should also be taken at 5 and 10 minute intervals, 
for, if the half-turbidity  point should be reached rapidly, extrapolation will indicate the 
approximate dilution of enzyme which will bring the half-point into the more accurate 
15 to 45 minute range.  If the half-point should fall in the 15 to 45 minute range, but 
not at 30  minutes,  the unitage is calculated by a  method  similar to  that used by 
McClean and Hale for the viscosimetric method; a graph of the turbidity against time 
will indicate the time at which half-turbidity  occurred.  However, a simple extrapola- 
tion on the assumption of a straight line reduction in turbidity with time gives results 
very close to those obtained by the use of the graph.  The calculation, when the time 
for half-turbidity to be attained has been determined, is the following:-- 
TurbidiW-reducing units  -- 
Standard time (30 rain.) X reciprocal of the dilution of enzyme 
Time for half-turbidity to be attained 
Thus, if a  1 to 60 dilution of the enzyme brought about half-turbidity in 40 minutes, 
the enzyme solution contains 45 turbidity-reducing units. 
The turbidity reduction method for estimating hyaluronidase activity was compared 
with the viscosimetric method of McClean and Hale, and two turbidity-reduclng units 
were found equal to one viscosity-reducing unit.  The turbidity method eliminates 
the use of the viscometer with its attendant expenditure of time in cleaning, measure- 
ment, etc., and is more economical of materials than the viscosity method, since much 
less substrate is required to give measurable turbidity than to produce enough viscosity 
to allow accurate measurement of the half-point.  The chief disadvantage of the tur- 
bidity method is its dependence upon purified hyaluronic acid for a substmte.  Since 
the concentration of polysaccharide does not alter the time in which the half-viscosity 
point is reached, crude substrate solutions may be used in the viscosity method; in the 
turbidity method, on the other hand, changes in the concentration of substrate will 
affect the results, hence crude solutions of hyaluronic acid to be used for a substrate 
must first be adjusted so that 0.5 ml. produces the same degree of turbidity as is pro- 
duced by 0.2 mg. of polysaccharide.  Such solutions have been used to show the prob- 
able  enzyme  concentration  of  a  given  hyaluronidase preparation;  in  three  crude 
polysaccharide preparations so tested, determinations of the concentration of hyalu- 
ronidase agreed within 10 per cent with determinations using purified substrate.  Since 
insufficient numbers of samples have been tested to determine the accuracy with which 
the turbidity reduction method  can utilize crude hyaluronic acid, its use must,  at 
present, be confined to preliminary studies which will show the probable enzyme con- 
tent of an unknown solution; the final determination should be repeated with nurified 
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The use of crude polysaccharide to establish the approximate enzyme concentration 
will allow 500 to 600 determinations to be made from 250 mg. of purified hyaluronic 
acid.  Further study of the effect of the contaminating substances in the crude poly- 
saccharide solutions may indicate conditions under which the crude substrate may be 
utilized more accurately. 
The viscosimetric measurements of hyaluronidase activity followed the procedure 
of McClean and Hale  (23),  using crude umbilical cord polysaccharide, prepared  as 
before, but with the chloroform-butyl alcohol shakings halted before all the protein had 
been removed.  The alcohol-precipitated polysaccharide was dried in vacuo and dis- 
solved in pH 6.0 phosphate buffer (0.1 5) to such concentration that the solution had a 
relative viscosity of about 4 at 37°C.  i ml. of this solution was warmed in an Ostwald 
viscometer for 5 minutes at 37°C.,  and an equal amount of similarly warmed enzyme 
dilution (in the same buffer) was added.  The solutions were mixed by blowing and 
their  viscosities  measured.  The  foregoing method  was  calibrated  against  that  of 
McClean and Hale (who used citrate buffer at 34°C.) in order to obtain a conversion 
factor which would eliminate the troublesome use of 34°C.  Division by this factor, 
1.1, was used to convert the values obtained in subsequent studies at 37°C. to units 
:orresponding to those of McClean and Hale. 
EXPERIMENTAL 
Experiment  1.  Effect  of  Testicular  Extract  on  Phagocytosis of Group A  and 
Group C Streptococci 
Earlier  experiments  (9)  in which  loss  of capsules  was  accompanied  by in- 
creased susceptibility to phagocytosis are open to the criticism that the changes 
undergone  by  the  streptococci  as  a  result  of aging  or heat  treatment  could 
conceivably explain  the  increased phagocytosis.  To test  conclusively for an 
antiphagocytic effect of the capsule, young microorganisms are desirable, since 
they more closely approximate  the physiologic state  of bacteria during active 
infection.  Preliminary  studies  indicated  that  the  viability  of  streptococci 
is  not diminished  by exposure  to testicular  extract;  and,  since hyaluronidase 
will rapidly decapsulate groups A  and C streptococci, the enzyme was utilized 
in the  following experiments  to demonstrate  the  antiphagocytic effect  of the 
capsules  of these  organisms. 
The procedure for studying phagocytosis was a  modification of the whole blood 
method of Lyons and Ward (28); the organisms were grown in 20 per cent serum broth 
by adding a 1 : 10 inoculum from an 18 hour culture to previously warmed and aerated 
medium.  Afterincubation  for 1 hour, the cells were thrown down and suspended in 
0.1 volume of normal salt solution; the turbidity of the resulting suspension lies be- 
tween tubes 1 and 2 in the McFarland scale.  Each of a series of small serological tubes 
received 0.5 ml. of freshly defibrinated human blood, 0.05  ml. of the organism, and 0.1 
ml. of the appropriate enzyme solution or of saline.  The tubes were stoppered with 
paraffined corks and rotated at 37°C. for 15 minutes in a rotator making two revolu- 
tions per minute.  Smears were made from the tubes and stained with Wright's stain; 
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mined, as well as the per cent of active leukocytes.  The same procedure was followed 
in the control experiments with the Type I  pneumoeoccus,  except that the cultures 
were grown for 4 to 6 hours before use,  and, in one series of experiments, a drop of 
1:100 dilution  of the homologous  rabbit antiserum was added to each tube to aid 
phagocytosis. 
During the early studies, the organisms were grown in broth containing the enzyme, 
or else were centrifuged, treated with the enzyme, and washed before they were added 
to the blood.  Later experiments showed that the addition of testicular extract directly 
to the blood has no apparent inhibitory effect on the phagocytes, and in all subsequent 
work the enzyme was added directly to the blood and organisms without previously 
exposing the bacteria to the decapsulating agent. 
The results of a typical experiment are recorded in Table I; blood EHK had 
practically no opsonic activity for the group A, type 14  strain (S 23), but in- 
gestion of streptococci was greatly increased upon addition of testicular  extract 
TABLE I 
Phagocytosis of Group A  Streptococcus (S 23) by Normal  (EHK) and Immune (CVS) Human 
Blood in the Presence of Bovine Testicular Extract 
No. of cocci ingested  Active leukocytes  Blood  by 100 leukocytes 
CV8  ........................................ 
CVS +  testicular extract ...................... 
EHK ........................................ 
EHK +  tesficular extract ..................... 
258 
1289 
20 
1346 
per Cen~ 
37 
92 
2 
92 
to the system.  Similarly, although blood CVS, which was taken from a donor 
who had been infected with the strain some years previously, did phagocytose 
the  streptococci,  the  amount  of  phagocytosis  was  greatly  increased  upon 
addition of testicular extract.  If blood CVS was incubated with a  guinea pig 
virulent strain of group C streptococcus (M 4), the organisms which had been 
treated with testicular extract were so rapidly ingested that it was impossible 
to estimate accurately the extent of phagocytosis, whereas in the  control no 
bacteria were taken up by 100  leukocytes.  On the  other hand,  if a  mouse- 
virulent Type I  pneumococcus was substituted for the streptococci, there was 
no significant increase in phagocytosis in the tubes containing hyaluronidase. 
In the presence of the homologous antiserum, phagocytosis of the pneumococci 
was greatly increased, but testicular extract did not alter the degree of phago- 
cytosis. 
These experiments demonstrate that the removal of the capsule by testicular 
extract greatly increases the rate of phagocytosis of groups A and C streptococci. 
The  effect seems  to  be specific,  since  testicular  extract  does  not  affect  the 
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Experiment 2.  Effect of Testicular Extract on the Bactericidal  Action of 
Defibrinated  Human Blood on Group A  Streptococci, 
Type 14 (S 23) 
In order to learn whether the increased phagocytosis of strain S 23 in the presence 
of testicular extract will lead to killing of the ingested organisms, bactericidal experi- 
ments were carried out in the same way as were the phagocytosis experiments, except 
that each tube received one drop of the appropriate dilution in broth of an  18 hour 
culture of the streptococcus.  The tubes were rotated for 6 hours, washed into Petri 
dishes, and agar added.  Typical results, presented in Table II, demonstrate the en- 
hancement of the bactericidal activity of whole blood by testicular extract; control 
experiments using sensitized and unsensitized Type I  pneumococci gave no evidence 
of increased killing as a function of the added testicular extract.  The regularly occur- 
TABLE II 
Bactericidal Effect of Normal (EHK) and Immune (CVS) Human Blood on Group A 
Streptococcus (S 23) in Presence of Testicular Extract 
Colony count after 6 hrs.' incubation with indicated number of organisms 
No. of organisms added in one drop 
Blood 
cgs  .............................. 
CVS +  testicular extract  ........... 
EHK ............................ 
EHK +  testicular extract .......... 
100,000  10,000  1,000  100  10 
41  28  --  [  --  -- 
oo  71  5  ] 
oo  ~o  oo  40  22 
oo  190  --  --  -- 
The symbol ~o indicates a plate on which colonies were too numerous to count. 
ring inhibition of the killing power of immune  blood in  the presence of testicular 
extract suggests either a  non-specific relative inhibition of phagocytic activity, or a 
more specific competition between the enzyme molecule and the opsonizing antibody 
for the surface of the bacteria. 
Experiment 3.  Protective Effect of Testicular  Extract on Experimental Group A 
Streptococcus Infection in Mice 
For reasons  which  will be  discussed,  the enzyme  treatment  used by other 
workers (2, 5, 6) in their unsuccessful attempts to protect mice against group A 
streptococcal infection, appeared to be inadequate; experiments were therefore 
performed in which more intensive enzyme treatment was administered. 
Groups of Swiss mice were injected intraperitoneally with appropriate dilutions of 
a 3½ hour culture of the test organism, grown from a  1 : 10 inoculum from an 18 hour 
culture.  The final dilutions were made in appropriate amounts of testicular extract 
and allowed to remain at room temperature for 5 minutes before injection; organisms 
intended for the control mice were diluted in plain broth.  Plate counts were made of 326  GROUP  A  HEMOLYTIC  STREPTOCOCCI 
the dilutions injected.  In a typical experiment, 0.4 ml. of the culture  dilutions were 
injected and treatment begun 2 hours later with 0.5 ml. of the crude testicular  extract 
containing  200 turbidity-reducing  units or 100 viscosity-reducing units of hyaluroni- 
dase.  The therapeutic  injections, administered  intraperitoneaUy, were given every 2 
hours for the first 12 hours, every 4 hours for the next 36 hours, and every 12 hours for 
the last 48 hours. 
The results  of typical experiments are tabulated in Tables III, IV, and V. 
It is  noteworthy that in  all  these  experiments,  young, physiologically active 
bacteria were injected, whereas in the unsuccessful experiments of other workers 
TABLE III 
Protective Effect of Bovine Testicular Extract on Mice Infected with Group A Streptococci, Type 
14 (S 23) 
Treated  with 
testicular 
extract  Virulence controls  Treated with testlcular  extract  heated at 
60°C. for 
MouseNo  30 min. 
Dilution of culture 
10  "~  10-4  10-~  10  ~  10  ~  10-4 
D1 
D1 
D1 
D1 
D1 
D1 
D1 
D1 
10-~ 
D2 
D2 
D2 
D2 
D3 
D4 
S 
S 
D1 
D2 
D2 
D2 
D2 
D2 
D2 
S 
D2 
D2 
D3 
D4 
D5 
D8 
D9 
D12 
D9 
S 
S 
S 
S 
S 
S 
S 
D4 
D5 
D7 
S 
S 
S 
S 
S 
D1 
D2 
D2 
D2 
D2 
D2 
D2 
D2 
D, with a number, indicates death within that number of days.  S means survival through- 
out the time of experiment, 14 days. 
18 hour cultures were used.  Presumably infection would be established more 
rapidly  by  the  former  method  which  therefore  constitutes  a  more  severe 
test of the therapeutic agent.  In Table III, the results of an early experiment 
using  type  14,  group A  streptococcal strain  S  23  are presented;  the  colony 
count of the 10  -5 dilution in this experiment  was 68 colonies  in 0.4 ml.  These 
experiments  have  been  repeated  with  different  preparations  of  the  enzyme 
with  essentially  the  same results.  The protective  action,  which  is  effective 
against  10 to  100 M.L.D., is destroyed by heating at 50°C. for 1 hour.  Since 
Hirst (2) failed to demonstrate protection against strain D  58 (type 3) as well 
as S 23, we also tested the former strain.  Table IV shows that protection was 
obtained, even though the 10  "-~ dilution of the culture used contained 80 colonies 
(more  than  10 ~r.L.D.) in  the  infecting  dose.  The  experiment  tabulated  in E.  H.  KASS AND C.  V.  SEASTONE  327 
Table V shows that the protection is specific; in this the Type I pneumococcus 
was used as the infecting agent and treatment was carried out with the enzyme 
TABLE IV 
Protective Effect of Bovine Testicular Extract on Mice Infected witk Group A  Streptococci, Type 
3 (DSg) 
! 
Virulence controls  I  Treated with testicular extract 
Mouse No.  Dilution o[ culture 
10-4  10-5  10-6  10-4  10-~  10-~ 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
D1 
D1 
D1 
D1 
D1 
D1 
D1 
D1 
D1 
D1 
D1 
D1 
D1 
D1 
D1 
D1 
D1 
D1 
D2 
D2 
D1 
D1 
D1 
D1 
D2 
D2 
D2 
D2 
D2 
D2 
D1 
D1 
D1 
D2 
D2 
D3 
S 
S 
S 
S 
D2 
D2 
D2 
D4 
S 
S 
S 
S 
S 
S 
D2 
D2 
D2 
D3 
D6 
S 
S 
S 
S 
S 
D, with a number, indicates death within that number of days.  S means survival through- 
out the time of the experiment,  8 days. 
TABLE V 
Protective Effect of Bovine Testicular Extract on Mice Infected witk Type I Pneumococcus 
I 
Virulence controls  [  Treated with testicular extract 
Mouse No.  Dilution of culture 
10-~  10-$  I0  -e  10-4  10s  10-6 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
D2 
D2 
D2 
D2 
D2 
]32 
D2 
D2 
D2 
D2 
D1 
D1 
D1 
D2 
D2 
D2 
D2 
D2 
D2 
S 
D2 
D2 
D2 
D2 
D2 
D2 
D2 
D2 
D2 
S 
DI 
D1 
D1 
D1 
D1 
D1 
D1 
DI 
D1 
D1 
DI 
DI 
DI 
DI 
DI 
D2 
D2 
D2 
D2 
D2 
D1 
D1 
D1 
D1 
D1 
DI 
D1 
D2 
D2 
D2 
D, with a number, indicates death within that number of days.  S means survival through- 
out the time of experiment,  8 days. 
preparation  that had protected against  strain  D  58.  The hyaluronidase  not 
only failed to protect against the Type I  pneumococcal infecti6n, but seemed 
to hasten the fatal outcome; a study of the time of death of the mice strikingly 
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DISCUSSION 
The consistent presence of hyaluronic acid in group A streptococci  isolated 
from human infections  (7)  indicates  the likelihood of a  more  important r61e 
for the polysaccharide  than has been accepted  by Hirst and Lancefield (2, 3); 
that  the polysaccharide  is  a  significant  factor in virulence  is  demonstrated 
by the experiments reported in this paper.  Lancefield has shown that the M 
protein, which is partly responsible for the type specificity of group A strepto- 
cocci, will give rise to protective antisera; and Mudd et aL, using old cultures 
which  lacked  capsules,  showed  that virulent strains  of streptococci  are  less 
readily phagocytosed than  non-virulent variants  of  the  same  strain  (29). 
While it is thus apparent that factors other than hyaluronic acid contribute to 
the virulence of group  A streptococci,  the ability of hyaluronidase to promote 
phagocytosis and bactericidal activity, as well as to protect against infection 
in mice, shows that hyaluronic acid is fundamentally  connected with virulence. 
The relation of the M substance to virulence remains an open question,  since 
it has been obtained in equally large amounts from both virulent and avirulent 
strains (30).  Furthermore, the production of protective antibodies  does not 
necessarily depend upon an antigen closely related to virulence, for non-type- 
specific protection may be stimulated by rough,  avirulent pneumococci  (31). 
The possibility  that hyaluronic acid and the M  protein are associated  in a 
virulent strain has been pointed out (7). 
That protection against group C infection by hyaluronidase has been more 
readily attained than protection against group A streptococci may be explained 
by the observation  that the group  C  infections  under investigation develop 
more slowly, and produce  a fatal termination anywhere from 12  to 24 hours 
later than do the more rapidly developing group A infections, possibly as an 
expression of different growth rates.  It is thus reasonable to suppose that the 
defense mechanisms of the host have a certain initial advantage in the group 
C infections, so that a larger amount of enzyme is necessary to protect against 
the group A organisms. 
Another reason for the failure of previous workers to protect against group A 
infection with hyaluronidase may be surmised from the work of McClean (6) 
who demonstrated that the sera of many animals,  including mice, inhibit the 
activity of the enzyme.  McClean studied the decapsulating effect of hyaluroni- 
dase  in mice  and pointed out  that  100  viscosity-reducing  units  of  enzyme 
maintained complete decapsulation for only about 1½ hours; yet in his attempts 
to demonstrate protection against streptococcal  infection, he used but 10 such 
units and injected them at 8 hour intervals, in accordance with the procedure 
of Hirst.  The  absence  of protection  in  such  an  experiment  may welt be 
explained  on a purely quantitative basis.  McClean (32) has suggested  that 
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preparation which he used.  Highly purified hyaluronidase was more rapidly 
removed from the blood stream than a  crude preparation of the enzyme. 
The inhibition of the bactericidal effect of immune whole blood by hyaluroni- 
dase  is  difficult to  explain.  While  the high concentration of hyaluronidase 
might  suggest  a  non-specific  inhibition  of  the  bactericidal  system  by  the 
enzyme, the fact that the enzyme greatly increases the killing power of non- 
immune blood  seems  to  contradict  such  an  explanation.  Another possible 
explanation is  that  the  anti-M  opsonin and hyaluronidase compete for  the 
surface  of  the  streptococcal  cell,  so  that  the  subsequent  steric  hindrance 
between the  two molecules  in some way decreases  the  ultimate phagocytic 
response.  Such an explanation is based on the assumption that the M protein 
is at or near the capsular surface, an assumption which is borne out by the fact 
that anti-M antibody opsonizes encapsulated streptococci, and by the observa- 
tion of Lancefield (3)  that streptococci treated with trypsin may lose  their 
type specificity without apparent loss  of any vital function. 
SUMMARY 
1.  A quantitative turbidimetric method for the estimation of hyaluronidase 
activity, based on the ability of the enzyme to decrease the capacity of the 
polysaccharide  to  precipitate  acidified  protein  has  been  developed.  Two 
units of hyaluronidase, by this method, are equivalent to one viscosity-reducing 
unit. 
2.  Hyaluronidase  added  to  a  phagocytic  system  containing  defibrinated 
human blood, immune or non-immune, greatly increases the rate of phagocyto- 
sis  of  group  A  streptococci.  Phagocytosis  of  Type  I  pneumococci  is  not 
affected by hyaluronidase under the same conditions. 
3.  The bactericidal activity of non-immune blood against group A strepto- 
cocci is increased by hya]uronidase; the activity of immune blood is, however, 
somewhat inhibited by the enzyme.  Killing of pneumococci  is not affected 
by the presence of the enzyme. 
4.  Mice can be protected against group A streptococcal infection by frequent 
treatment with 200 turbidity-reducing units of hyaluronidase; the protective 
action of the enzyme is removed by heating at 60°C.  for 1  hour.  Mice  in- 
fected with Type I pneumococcus and treated with hyaluronidase die somewhat 
sooner than the untreated controls. 
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